Literature DB >> 30632819

Serum and peritoneal fluid levels of interleukin-6 and interleukin-37 as biomarkers for endometriosis.

Jianfa Jiang1, Zhaoying Jiang1, Min Xue1.   

Abstract

This study aimed to compare the levels of interleukin (IL)-1β, IL-6, IL-10, and IL-37 in the serum and peritoneal fluid of women with and without endometriosis. In addition, it aimed to determine the diagnostic values of the cytokines with significantly different concentrations. The levels of IL-1β, IL-6, IL-10, and IL-37 in the serum and peritoneal fluid samples of 40 women with endometriosis and 32 women without endometriosis were measured using an enzyme-linked immunosorbent assay. The serum and peritoneal fluid levels of IL-1β and IL-10 were not statistically significantly different between the endometriosis and control groups. The IL-6 and IL-37 levels in the serum and peritoneal fluid were higher in the endometriosis group than in the control group, and they were correlated with the stage of endometriosis. The AUC for the IL-37 was 0.897 for the serum and 0.934 for the peritoneal fluid, while the AUC for the IL-6 was 0.905 for the serum and 0.952 for the peritoneal fluid. Our results suggest that the serum and peritoneal fluid IL-6 and IL-37 levels were significantly increased in the endometriosis patients, indicating that these cytokines may serve as biomarkers for the diagnosis of endometriosis.

Entities:  

Keywords:  Endometriosis; biomarker; interleukin-37; interleukin-6

Year:  2019        PMID: 30632819     DOI: 10.1080/09513590.2018.1554034

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  8 in total

1.  IL-37bΔ1-45 suppresses the migration and invasion of endometrial cancer cells by targeting the Rac1/NF-κB/MMP2 signal pathway.

Authors:  Xishuang Wang; Zengtao Wei; Zhongyun Tang; Chenyue Xue; Huayun Yu; Derui Zhang; Yulan Li; Xihong Liu; Yongyu Shi; Lining Zhang; Guoling Chen; Huaiyu Zhou; Jianing Wang; Xiaoyan Wang
Journal:  Lab Invest       Date:  2021-03-22       Impact factor: 5.662

2.  miR-424-5p combined with miR-17-5p has high diagnostic efficacy for endometriosis.

Authors:  Chunli Lin; Saili Zeng; Miaojie Li
Journal:  Arch Gynecol Obstet       Date:  2022-04-03       Impact factor: 2.344

3.  A randomized trial assessing the efficacy of Silymarin on endometrioma-related manifestations.

Authors:  Negin Mirzaei; Shahideh Jahanian Sadatmahalleh; Safoura Rouholamin; Malihe Nasiri
Journal:  Sci Rep       Date:  2022-10-20       Impact factor: 4.996

4.  Diagnostic Significance of Selected Serum Inflammatory Markers in Women with Advanced Endometriosis.

Authors:  Izabela Kokot; Agnieszka Piwowar; Marcin Jędryka; Katarzyna Sołkiewicz; Ewa Maria Kratz
Journal:  Int J Mol Sci       Date:  2021-02-25       Impact factor: 5.923

5.  Inflammatory signals induce MUC16 expression in ovarian cancer cells via NF-κB activation.

Authors:  Jie Liu; Li Li; Ning Luo; Qi Liu; Li Liu; Dandan Chen; Zhongping Cheng; Xiaowei Xi
Journal:  Exp Ther Med       Date:  2020-12-21       Impact factor: 2.447

6.  New rat to mouse xenograft transplantation of endometrium as a model of human endometriosis.

Authors:  Amir Abdolmaleki; Cyrus Jalili; Kamran Mansouri; Mitra Bakhtiari
Journal:  Animal Model Exp Med       Date:  2021-09-03

7.  Resveratrol treatment reduces expression of MCP-1, IL-6, IL-8 and RANTES in endometriotic stromal cells.

Authors:  Roya Kolahdouz-Mohammadi; Farzad Shidfar; Sepideh Khodaverdi; Tahereh Arablou; Sahel Heidari; Nesa Rashidi; Ali-Akbar Delbandi
Journal:  J Cell Mol Med       Date:  2020-12-15       Impact factor: 5.295

8.  Circulating Interleukin-37 Levels in Healthy Adult Humans - Establishing a Reference Range.

Authors:  Danielle M Santarelli; Fabien B Vincent; Ina Rudloff; Claudia A Nold-Petry; Marcel F Nold; Marc A Russo
Journal:  Front Immunol       Date:  2021-07-23       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.